About Sir Run Run Shaw Hospital
浙江大学医学院附属邵逸夫医院，又名浙江省邵逸夫医院，是附属于浙江大学医学部的一所三级甲等医院。设两个院区，庆春院区位于杭州市上城区庆春东路3号，地铁庆春广场站西侧。下沙院区位于杭州市钱塘区下沙路368号。两院区采用一体化管理模式，杭州公交298路在两院区之间互通。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
24
Sir Run Run Shaw Hospital
24
BeiGene
15
Janssen Research & Development, LLC
15
Pfizer
11
Eli Lilly and Company
10
Merck Sharp & Dohme LLC
8
Second Affiliated Hospital, School of Medicine, Zhejiang University
8
I-Mab Biopharma Co. Ltd.
5
Jiangsu HengRui Medicine Co., Ltd.
5
Lepu Medical Technology (Beijing) Co., Ltd.
5
Clinical Trials at Sir Run Run Shaw Hospital
During the past decade, Sir Run Run Shaw Hospital conducted 239 clinical trials. In the 10-year time frame, 239 clinical trials started and 36 clinical trials were completed, i.e. on
average, 15.1% percent of trials that started reached the finish line to date. In the past 5 years, 111 clinical trials started and 22 clinical trials were completed. i.e. 19.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
2009-08-25
2021-04-29
Completed
492
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
2008-07-28
2019-04-05
Terminated
888
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
2010-04-01
2012-08-01
Terminated
331
A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients
2010-09-09
2018-01-31
Completed
553
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
2011-07-01
2014-06-01
Completed
626
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy
2011-05-23
2017-08-17
Completed
276
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sir Run Run Shaw Hospital" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Sir Run Run Shaw Hospital" with 24 trials
sponsored, "BeiGene" with 15 trials sponsored, "Janssen Research & Development, LLC" with 15 trials sponsored and "Pfizer"
with 15 trials sponsored. Other sponsors include 186 different institutions and
companies that sponsored additional 115 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sir Run Run Shaw Hospital"
#1 collaborator was "Sir Run Run Shaw Hospital" with 21 trials as a collaborator, "Shanghai Zhongshan Hospital" with 9 trials as a collaborator, "RenJi Hospital" with 6 trials as a collaborator, "The First Hospital of Jilin University" with 6 trials as a collaborator and "Anhui Provincial Hospital" with 5 trials as a collaborator. Other collaborators include 441 different institutions and companies that were
collaborators in the rest 269 trials.
Clinical Trials Conditions at Sir Run Run Shaw Hospital
According to Clinical.Site data, the most researched conditions in "Sir Run Run Shaw Hospital" are
"Gastric Cancer" (11 trials), "Non-Small Cell Lung Cancer" (10 trials), "Coronary Artery Disease" (9 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials) and "Crohn Disease" (7 trials). Many other conditions were trialed in "Sir Run Run Shaw Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Sir Run Run Shaw Hospital
Most popular intervention types in "Sir Run Run Shaw Hospital" are "Drug" (198 trials), "Device" (33 trials), "Other" (23 trials), "Procedure" (20 trials) and "Biological" (19 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (54 trials), "Cisplatin" (18 trials), "Atezolizumab" (17 trials), "Capecitabine" (16 trials) and "Oxaliplatin" (13 trials). Other intervention names were less common.
Clinical Trials Genders at Sir Run Run Shaw Hospital
The vast majority of trials in "Sir Run Run Shaw Hospital" are
271 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Sir Run Run Shaw Hospital
Currently, there are 148 active trials in "Sir Run Run Shaw Hospital".
6 are not yet recruiting,
85 are recruiting,
55 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 79 completed trials in Sir Run Run Shaw Hospital,
1 suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Sir Run Run Shaw Hospital, 32 "Phase 1"
clinical trials were conducted, 58 "Phase 2" clinical
trials and 122 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 41 trials that are defined as “Not Applicable".